This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Everolimus for Patients With Relapsed/Refractory G...
Clinical trial

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (RADIT)

Read time: 1 mins
Last updated:16th Nov 2010
The purpose of this study is to determine whether the drug everolimus is effective in the treatment of patients with relapsed cancer of the testis.
Category Value
Study start date 2010-11-16

View full details